| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |